Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme

2002 ◽  
Vol 19 (12) ◽  
pp. 1014-1021 ◽  
Author(s):  
N. Younis ◽  
D. M. Broadbent ◽  
S. P. Harding ◽  
J. P. Vora
2020 ◽  
pp. bjophthalmol-2020-315886
Author(s):  
Maria Carolina Ibanez-Bruron ◽  
Ameenat Lola Solebo ◽  
Phillippa Cumberland ◽  
Jugnoo S Rahi

BackgroundWe investigated the incidence and causes of sight-threatening diabetes-related eye disease in children living with diabetes in the UK, to inform the national eye screening programme and enable monitoring of trends.MethodsWe undertook a prospective active national surveillance via the British Ophthalmic Surveillance Unit. Eligible cases were children aged 18 years or younger, with type 1 or 2 diabetes, newly diagnosed between January 2015 and February 2017 with sight-threatening diabetic eye disease.ResultsEight children were reported. The annual incidence of all sight-threatening diabetes-related eye disease requiring referral to an ophthalmologist among children living with diabetes (n=8) in the UK was 1.21 per 10 000 person-years (95% CI 0.52 to 2.39) and was largely attributable to cataract (n=5) 0.76 per 10 000 person-years (95% CI 0.25 to 1.77). The incidence of sight-threatening diabetic retinopathy (n=3) among those eligible for screening (12 to 18 year-olds living with diabetes) was 1.18 per 10 000 person-years (95% CI 0.24 to 3.46). No subjects eligible for certification as visually impaired or blind were reported.ConclusionsSecondary prevention of visual disability due to retinopathy is currently the sole purpose of national eye screening programmes globally. However, the rarity of treatment-requiring retinopathy in children/young people living with diabetes, alongside growing concerns about suboptimal screening uptake, merit new consideration of the utility of screening for primary prevention of diabetes-related morbidity by using the screening event and findings as a catalyst for better diabetes self-management.


2020 ◽  
Vol 26 (12) ◽  
pp. 1466-1474 ◽  
Author(s):  
Stephanie J. Fonda ◽  
Sven-Erik Bursell ◽  
Drew G. Lewis ◽  
Dawn Clary ◽  
Dara Shahon ◽  
...  

Diabetes Care ◽  
1990 ◽  
Vol 13 (8) ◽  
pp. 908-909 ◽  
Author(s):  
S. B. Baker ◽  
C. Vallbona ◽  
J. V. Campbell ◽  
M. B. Hamill ◽  
B. Goetz ◽  
...  

Author(s):  
Karen Whitehouse

Advanced diabetic eye disease can remain asymptomatic for a long time, due to the slow progression of proliferative retinopathy and the fact that the macula may not be affected. This chapter examines the progression of proliferative disease and its’ natural history if left untreated. Diabetic retinopathy screening is an important factor in intervention and treatment. The grading criteria for advanced disease (R3) as defined by the NHS Diabetic Eye screening Programme (NHSDESP) is discussed, as well as the management of the patient and subsequent treatment regimen.


2020 ◽  
pp. bjophthalmol-2020-317508
Author(s):  
Rajiv Pandey ◽  
Margaret M Morgan ◽  
Colette Murphy ◽  
Helen Kavanagh ◽  
Robert Acheson ◽  
...  

ObjectiveTo study the uptake of annual diabetic retinopathy screening and study the 5-year trends in the detection of screen-positive diabetic retinopathy and non-diabetes-related eye disease in a cohort of annually screened individuals.DesignRetrospective retinopathy screening attendance and retinopathy grading analysis.SettingCommunity-based retinopathy screening centres for the Diabetic RetinaScreen Programme.Participants171 557 were identified by the screening programme to be eligible for annual diabetic retinopathy screening. 120 048 individuals over the age of 12 consented to and attended at least one screening appointment between February 2013 to December 2018.Main Outcome MeasuresDetection rate per 100 000 of any retinopathy, screen-positive referrable retinopathy and nondiabetic eye disease.ResultsUptake of screening had reached 67.2% in the fifth round of screening. Detection rate of screen-positive retinopathy reduced from 13 229 to 4237 per 100 000 screened over five rounds. Detection of proliferative disease had reduced from 2898 to 713 per 100 000 screened. Non-diabetic eye disease detection and referral to treatment centres increased almost eightfold from 393 in round 1 to 3225 per 100 000 screened. The majority of individuals referred to treatment centres for ophthalmologist assessment are over the age of 50 years.ConclusionsScreening programme has seen a reduced detection rate both screen-positive retinopathy referral in Ireland over five rounds of screening. Management of nondiabetic eye diseases poses a significant challenge in improving visual outcomes of people living with diabetes in Ireland.


2016 ◽  
Vol 47 (10) ◽  
pp. 930-934 ◽  
Author(s):  
Fabiana Q. Silva ◽  
Mehreen Adhi ◽  
Karen M. Wai ◽  
Leann Olansky ◽  
M. Cecilia Lansang ◽  
...  

1996 ◽  
Vol 89 (5) ◽  
pp. 463-470 ◽  
Author(s):  
KENNETH J. FRANK ◽  
J PAUL DIECKERT

Sign in / Sign up

Export Citation Format

Share Document